Related Experiment Video
Updated: May 20, 2026
06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
MicroRNA-29: a potential therapeutic target for systemic sclerosis
Wen-Jia Peng1, Jin-Hui Tao, Bin Mei
1Anhui Medical University, School of Public Health, Department of Epidemiology and Biostatistics, Hefei, Anhui, PR China.
Expert Opinion on Therapeutic Targets
|July 17, 2012
Summary
Targeting microRNAs (miRNAs), specifically miRNA-29, shows promise for treating systemic sclerosis (SSc). This approach addresses the disease
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Systemic sclerosis (SSc) is an autoimmune disease with unknown etiology, characterized by fibrosis and organ damage.
- Current treatments for SSc are limited due to incomplete understanding of its pathogenesis.
- MicroRNAs (miRNAs) are key regulators of gene expression, with miRNA-29 implicated in fibrotic diseases.
Purpose of the Study:
- To review the biogenesis and function of miRNAs.
- To examine the role of miRNA-29 in SSc pathogenesis and fibrosis.
- To explore the therapeutic potential of targeting miRNA-29 in SSc.
Main Methods:
- Comprehensive literature review on miRNA biogenesis and function.
- Analysis of aberrant miRNA-29 expression in SSc.
- Summary of current research on miRNA-29's role in fibrosis.
- Discussion of therapeutic strategies targeting miRNA-29.
Main Results:
- miRNA-29 is involved in extracellular matrix (ECM) production and organ fibrosis.
- Aberrant expression of miRNA-29 is observed in SSc.
- miRNA-29 plays a significant role in the fibrotic processes within SSc.
Conclusions:
- Targeting miRNA-29 presents a potential therapeutic strategy for SSc.
- Further research is needed to fully elucidate SSc pathogenesis and optimize miRNA-29-based therapies.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...